AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

4DMEDICAL LTD

3.830

-0.190-4.73%

Volume:3.08M

Turnover:11.99M

Market Cap:2.29B

PE:-9.28

High:3.980

Open:3.980

Low:3.810

Close:4.020

52wk High:7.550

52wk Low:0.472

Shares:597.56M

Float Shares:377.76M

Volume Ratio:0.73

T/O Rate:0.82%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.413

EPS(LYR):-0.140

ROE:-1099.31%

ROA:-26.14%

PB:-80.58

PE(LYR):-27.36

Loading ...

Overview Company News Filings

4dmedical Wins TGA Approval for CT:VQ Lung Imaging Software in Australia

4DMedical (ASX:4DX) Draws Investor Focus As Conference Update Tests Its Undervalued Narrative

Simply Wall St.

Stock Track | 4DMedical Plummets 11.38% Intraday Despite Securing TGA Approval for CT:VQ Imaging Technology

4dmedical Receives TGA Approval for CTVQ in Australia

Stock Track | 4DMedical Soars 8.32% Intraday on TGA Approval for CT:VQ Imaging Software

4DMedical's Imaging Technology Secures TGA Approval

MT Newswires Live

4dmedical - Receives Tga Approval for Ct:vq in Australia

THOMSON REUTERS

Stock Track | 4DMedical Soars 6.34% Intraday as JPMorgan Chase Acquires 5.27% Stake

4DMedical Says JPMorgan Chase Acquires 5.27% Stake

MT Newswires Live

4DMedical (ASX:4DX) Is Up 25.5% After US CT:VQ Win And SimonMed Deal - What's Changed

Simply Wall St.

4DMedical (ASX:4DX) Shares Could Be 59.1% Undervalued After Philips Webinar Interest

Simply Wall St.

bioAffinity Technologies to host veteran lung health screening webinar with Philips, 4DMedical

Is 4DMedical’s (ASX:4DX) Global Lung Imaging Push Reframing Its Core Investment Narrative?

Simply Wall St.

4DMedical Launches CLEAR Clinical Program to Target $3 Billion Pulmonary Embolism Market

MT Newswires Live

Stock Track | 4DMedical Soars 5.38% Intraday on Launch of Clinical Evidence Program to Fast-Track Pulmonary Embolism Market Entry

BRIEF-4Dmedical Launches Clear Clinical Evidence Program

4DMedical Ltd - Launches Clear Clinical Evidence Program Designed to Fast-Track Ct:Vq™ Entry Into Acute Pulmonary Embolism (Pe) Market

THOMSON REUTERS

Does 4DMedical’s (ASX:4DX) CT:VQ Clinical Focus Reframe Its Technology Adoption and Earnings Story?

Simply Wall St.

BRIEF-4Dmedical Creates EU Platform Via Contextflow Acquisition

BUZZ-Australia's 4DMedical rises on establishing European platform via acquisition

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/4DX.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"4DX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"4DX.AU\",,,,,undefined,":{"symbol":"4DX.AU","market":"AU","secType":"STK","nameCN":"4DMEDICAL LTD","latestPrice":3.83,"timestamp":1787292720000,"preClose":4.02,"halted":0,"volume":3079212,"delay":0,"changeRate":-0.04726368159203968,"nameEN":"4DMEDICAL LTD","floatShares":377762864,"shares":597559121,"eps":-0.412693,"marketStatus":"Market Closed","change":-0.19,"latestTime":"08-21 16:12:00 AEST","open":3.98,"high":3.98,"low":3.81,"amount":11985873,"amplitude":0.042289,"askPrice":3.87,"askSize":2289,"bidPrice":3.83,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.412693,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":4.02,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":0.7300431006290026,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"4DX.AU","preClose":4.02,"auctionPrice":3.83,"auctionVolume":238736,"auction":3,"marketStatus":"盘后竞价","timestamp":1787292600246}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"4DX.AU\",,,,,undefined,":{"symbol":"4DX.AU","floatShares":377762864,"roa":"-26.14%","roe":"-1099.31%","lyrEps":-0.14,"volumeRatio":0.7300431006290026,"shares":597559121,"dividePrice":0,"high":3.98,"amplitude":0.042289,"preClose":4.02,"low":3.81,"week52Low":0.472,"pbRate":"-80.58","psRate":"393.89","week52High":7.55,"institutionHeld":0,"latestPrice":3.83,"committee":-0.391912,"eps":-0.412693,"divideRate":0,"volume":3079212,"delay":0,"ttmEps":-0.412693,"open":3.98,"prevYearClose":3.93,"prevWeekClose":3.64,"prevMonthClose":3.63,"prevQuarterClose":4.53,"fiveDayClose":3.64,"twentyDayClose":3.11,"sixtyDayClose":3.34},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/4DX.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"4DX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"4DX.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2647475443","title":"4dmedical Wins TGA Approval for CT:VQ Lung Imaging Software in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2647475443","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647475443?lang=en_us&edition=fundamental","pubTime":"2026-06-29 10:43","pubTimestamp":1782701028,"startTime":"0","endTime":"0","summary":"4DMedical wins TGA approval for CT:VQ lung imaging software in Australia4DMedical secured Australian TGA clearance for CT:VQ, enabling commercial rollout nationwide via inclusion on the ARTG.CT:VQ gen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDL50ftKS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646247319","title":"4DMedical (ASX:4DX) Draws Investor Focus As Conference Update Tests Its Undervalued Narrative","url":"https://stock-news.laohu8.com/highlight/detail?id=2646247319","media":"Simply Wall St.","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646247319?lang=en_us&edition=fundamental","pubTime":"2026-06-28 04:17","pubTimestamp":1782591454,"startTime":"0","endTime":"0","summary":"Conference presentation draws investor attention to 4DMedical\nInvestor interest in 4DMedical (ASX:4DX) has picked up ahead of the company’s presentation at the Life Sciences Virtual Investor Forum on June 24, where CEO Andreas Fouras is scheduled to outline current priorities.\nThe event gives current and prospective shareholders a chance to hear directly from management about 4DMedical’s respiratory imaging technology portfolio and how the business is positioned across the United States and...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/4dmedical-asx4dx-draws-investor-focus-as-conference-update-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/4dmedical-asx4dx-draws-investor-focus-as-conference-update-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7094","4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106251289","title":"Stock Track | 4DMedical Plummets 11.38% Intraday Despite Securing TGA Approval for CT:VQ Imaging Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=1106251289","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106251289?lang=en_us&edition=fundamental","pubTime":"2026-06-26 11:20","pubTimestamp":1782444032,"startTime":"0","endTime":"0","summary":"4DMedical Ltd's shares plummeted 11.38% intraday on Friday, a significant move that followed the company's announcement of receiving Therapeutic Goods Administration (TGA) approval for its CT:VQ...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646528380","title":"4dmedical Receives TGA Approval for CTVQ in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2646528380","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646528380?lang=en_us&edition=fundamental","pubTime":"2026-06-26 09:31","pubTimestamp":1782437505,"startTime":"0","endTime":"0","summary":"June 26 (Reuters) - 4DMedical Ltd <4DX.AX>::*RECEIVES TGA APPROVAL FOR CT:VQ IN AUSTRALIA*Further company coverage: 4DX.AX* ((Reuters.Briefs@thomsonreuters.com;))((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))Source Date/Time = 26-JUN-202601:22:51 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nRSD3p0wkh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["4DX.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136674705","title":"Stock Track | 4DMedical Soars 8.32% Intraday on TGA Approval for CT:VQ Imaging Software","url":"https://stock-news.laohu8.com/highlight/detail?id=1136674705","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136674705?lang=en_us&edition=fundamental","pubTime":"2026-06-26 08:02","pubTimestamp":1782432150,"startTime":"0","endTime":"0","summary":"4DMedical Ltd's stock soared 8.32% intraday on Friday following a significant regulatory milestone for the company's flagship technology.The surge comes after the company announced it received...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646672384","title":"4DMedical's Imaging Technology Secures TGA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2646672384","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646672384?lang=en_us&edition=fundamental","pubTime":"2026-06-26 07:11","pubTimestamp":1782429108,"startTime":"0","endTime":"0","summary":"4DMedical  secured Therapeutic Goods Administration  approval and inclusion on the Australian Register of Therapeutic Goods for its non-contrast ventilation-perfusion imaging software CT:VQ, enabling commercial use across Australia, according to a Friday Australian bourse filing.The technology derives regional ventilation and perfusion information from standard non-contrast computed tomography  scans without the need for injections, contrast agents, or nuclear medicine infrastructure, per the filing.The company said CT:VQ is well positioned for scalable adoption across both urban and regional healthcare settings in Australia, where high CT scanner density could help improve access to functional lung imaging, the filing said.The company will now seek Medicare reimbursement through the Medical Services Advisory Committee, backed by clinical and health-economic evidence as well as real-world usage data, the filing added.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XAO.AU","XJO.AU","VAP.AU","OZR.AU","GIVE.AU","QFN.AU","BK7001","VAS.AU","TGA.AU","QRE.AU","BBOZ.AU","STW.AU","ZYAU.AU","IIGF.AU","OZF.AU","BK7094","XKO.AU","IOZ.AU","4DX.AU","E200.AU","IISV.AU","GEAR.AU","DACE.AU","BEAR.AU","EIGA.AU","IMLC.AU","SLF.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646381905","title":"4dmedical - Receives Tga Approval for Ct:vq in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2646381905","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646381905?lang=en_us&edition=fundamental","pubTime":"2026-06-26 06:18","pubTimestamp":1782425899,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nFWN42X0DO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["4DX.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155658041","title":"Stock Track | 4DMedical Soars 6.34% Intraday as JPMorgan Chase Acquires 5.27% Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=1155658041","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155658041?lang=en_us&edition=fundamental","pubTime":"2026-06-24 10:58","pubTimestamp":1782269907,"startTime":"0","endTime":"0","summary":"4DMedical Ltd's stock soared 6.34% during intraday trading on Wednesday, following news of significant institutional investment in the company.The surge came after the company disclosed that JPMorgan...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645866526","title":"4DMedical Says JPMorgan Chase Acquires 5.27% Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2645866526","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645866526?lang=en_us&edition=fundamental","pubTime":"2026-06-24 10:55","pubTimestamp":1782269743,"startTime":"0","endTime":"0","summary":"4DMedical (ASX:4DX) said JPMorgan Chase and its affiliates acquired voting power of 5.27% in the firm as of June 19, becoming a substantial holder, according to a Wednesday Australian bourse filing.JPMorgan Chase now holds 31.4 million ordinary shares of the firm.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0868494708.USD","LU1267930490.SGD","LU2552382215.SGD","LU2054465674.USD","LU2552382058.USD","LU1363072403.SGD","IE00BWXC8680.SGD","LU2023250504.SGD","LU2456880835.USD","4DX.AU","BK4585","IE00BYXW3230.USD","IE00B3S45H60.SGD","LU2106854487.HKD","LU2430703178.SGD","JPX","LU2552382132.HKD","LU0211327993.USD","LU1116320901.HKD","LU2430703095.HKD","LU1668664300.SGD","LU2746668974.SGD","LU1894683264.USD","BK4533","LU0417517546.SGD","JPMO","LU0211328371.USD","IE00B775SV38.USD","LU0496365809.HKD","LU2023250843.SGD","PGF","IE00BJLML261.HKD","IE00BKVL7J92.USD","LU0251132253.USD","LU0345769128.USD","BK4566","LU0859254822.USD","JPO","LU0211326755.USD","LU0256863902.USD","IE00BZ1G4Q59.USD","IE00BLSP4239.USD","LU0208291251.USD","LU1917777945.USD","LU2237443549.SGD","JPM","LU0323591593.USD","LU0106261372.USD","LU0345769631.USD","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645075456","title":"4DMedical (ASX:4DX) Is Up 25.5% After US CT:VQ Win And SimonMed Deal - What's Changed","url":"https://stock-news.laohu8.com/highlight/detail?id=2645075456","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645075456?lang=en_us&edition=fundamental","pubTime":"2026-06-22 22:22","pubTimestamp":1782138141,"startTime":"0","endTime":"0","summary":"4DMedical has recently gained US FDA 510(k) clearance for its CT:VQ lung imaging software, launched the CLEAR clinical evidence program for pulmonary embolism, agreed to acquire Austrian AI imaging firm contextflow, and signed a commercial contract with SimonMed Imaging in the US outpatient market.\nTogether, these steps expand 4DMedical’s obtainable US CT:VQ market to about US$3.00 billion while creating an immediate European commercial footprint and new software-as-a-service distribution...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/4dmedical-asx4dx-is-up-255-after-us-ctvq-win-and-simonmed-de","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/4dmedical-asx4dx-is-up-255-after-us-ctvq-win-and-simonmed-de","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7094","4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645096591","title":"4DMedical (ASX:4DX) Shares Could Be 59.1% Undervalued After Philips Webinar Interest","url":"https://stock-news.laohu8.com/highlight/detail?id=2645096591","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645096591?lang=en_us&edition=fundamental","pubTime":"2026-06-20 23:23","pubTimestamp":1781969036,"startTime":"0","endTime":"0","summary":"Recent attention on 4DMedical (ASX:4DX) has been tied to its participation in a joint webinar with Philips and bioAffinity Technologies on diagnostic and imaging tools for U.S. veterans, alongside a recent move in the share price.\nSee our latest analysis for 4DMedical.\nThe recent webinar news comes on top of strong momentum in 4DMedical’s share price, with a 1 month share price return of 38.41% and a 7 day move of 23.37%. The 1 year total shareholder return is also extremely large, indicating...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/4dmedical-asx4dx-shares-could-be-591-undervalued-after-phili","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/4dmedical-asx4dx-shares-could-be-591-undervalued-after-phili","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["4DX.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643095754","title":"bioAffinity Technologies to host veteran lung health screening webinar with Philips, 4DMedical","url":"https://stock-news.laohu8.com/highlight/detail?id=2643095754","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643095754?lang=en_us&edition=fundamental","pubTime":"2026-06-16 20:06","pubTimestamp":1781611578,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies will host a lung health screening webinar for U.S. veterans on July 21, 2026 at 6 p.m. ET.Session will highlight lung cancer screening approaches, imaging advances, noninvasive diagnostics such as CyPath Lung, access to follow-up care.Webinar features speakers from Philips, 4DMedical, RWJBarnabas Health; NAVREF’s Rashi Romanoff will moderate.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. bioAffinity Technologies Inc. published the original content used to generate this news brief via Business Wire  on June 16, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL7lTMGv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAF","BK7094","4DX.AU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643624352","title":"Is 4DMedical’s (ASX:4DX) Global Lung Imaging Push Reframing Its Core Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2643624352","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643624352?lang=en_us&edition=fundamental","pubTime":"2026-06-14 10:13","pubTimestamp":1781403221,"startTime":"0","endTime":"0","summary":"In late May 2026, 4DMedical launched its CLEAR clinical evidence program in the U.S. to support CT:VQ™ use in pulmonary embolism diagnosis and acquired Austria-based contextflow GmbH to add AI-driven lung imaging capabilities in Europe.\nTogether, these moves indicate 4DMedical is attempting to build a more comprehensive global lung imaging platform by pairing clinical validation with AI-enabled software.\nWe’ll now examine how the contextflow acquisition and related global expansion efforts...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/is-4dmedicals-asx4dx-global-lung-imaging-push-reframing-its","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/is-4dmedicals-asx4dx-global-lung-imaging-push-reframing-its","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7094","AGIX","4DX.AU","CHAT","ARTY","BK4588","AIPO","AI","BK4528","AIYY","BK4551","BK4585","BK4587","BK4023","BK4543"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640998020","title":"4DMedical Launches CLEAR Clinical Program to Target $3 Billion Pulmonary Embolism Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2640998020","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640998020?lang=en_us&edition=fundamental","pubTime":"2026-06-02 08:20","pubTimestamp":1780359607,"startTime":"0","endTime":"0","summary":"4DMedical  launched CLEAR, a clinical evidence program designed to accelerate entry of its CT:VQ imaging technology into the acute pulmonary embolism market, targeting a $3 billion obtainable market in the US, according to a Tuesday Australian bourse filing.The company said the core CLEAR study, which stands for Contrast-free Lung Evaluation for Acute Risk in pulmonary embolism, is a multi-center, multinational, prospective, observational study putting CT:VQ head-to-head with computed tomography pulmonary angiography in patients with suspected pulmonary embolism, the filing added.4DMedical has entered into a clinical research agreement with Mass General Brigham-affiliated teaching hospitals as the lead site for CLEAR, it added.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7094","4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123684629","title":"Stock Track | 4DMedical Soars 5.38% Intraday on Launch of Clinical Evidence Program to Fast-Track Pulmonary Embolism Market Entry","url":"https://stock-news.laohu8.com/highlight/detail?id=1123684629","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123684629?lang=en_us&edition=fundamental","pubTime":"2026-06-02 08:03","pubTimestamp":1780358589,"startTime":"0","endTime":"0","summary":"4DMEDICAL LTD's stock surged 5.38% during Tuesday's intraday trading session following the company's announcement of a new initiative to accelerate its market expansion.The medical technology company...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640998634","title":"BRIEF-4Dmedical Launches Clear Clinical Evidence Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2640998634","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640998634?lang=en_us&edition=fundamental","pubTime":"2026-06-02 07:52","pubTimestamp":1780357972,"startTime":"0","endTime":"0","summary":"BRIEF-4Dmedical Launches Clear Clinical Evidence ProgramJune 2 (Reuters) - 4DMedical Ltd 4DX.AX:LAUNCHES CLEAR CLINICAL EVIDENCE PROGRAM DESIGNED TO FAST-TRACK CT:VQ™ ENTRY INTO ACUTE PULMONARY EMBOLISM (PE) MARKETFurther company coverage: 4DX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nFWN4290RL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["4DX.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640960526","title":"4DMedical Ltd - Launches Clear Clinical Evidence Program Designed to Fast-Track Ct:Vq™ Entry Into Acute Pulmonary Embolism (Pe) Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2640960526","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640960526?lang=en_us&edition=fundamental","pubTime":"2026-06-02 06:31","pubTimestamp":1780353067,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nFWN4290RL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["4DX.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640685879","title":"Does 4DMedical’s (ASX:4DX) CT:VQ Clinical Focus Reframe Its Technology Adoption and Earnings Story?","url":"https://stock-news.laohu8.com/highlight/detail?id=2640685879","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640685879?lang=en_us&edition=fundamental","pubTime":"2026-06-01 22:21","pubTimestamp":1780323691,"startTime":"0","endTime":"0","summary":"In May 2026, 4DMedical held a special call to present on the clinical use of its CT:VQ technology, highlighting how the platform may be applied in real-world respiratory imaging. \nThis focused discussion on CT:VQ’s clinical role adds fresh context to earlier expectations that the technology could open access to a large VQ imaging market. \nWe’ll now examine how this CT:VQ clinical-use call may influence 4DMedical’s investment narrative built around technology adoption and earnings...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/does-4dmedicals-asx4dx-ctvq-clinical-focus-reframe-its-techn","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/does-4dmedicals-asx4dx-ctvq-clinical-focus-reframe-its-techn","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640981707","title":"BRIEF-4Dmedical Creates EU Platform Via Contextflow Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2640981707","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640981707?lang=en_us&edition=fundamental","pubTime":"2026-06-01 09:03","pubTimestamp":1780275828,"startTime":"0","endTime":"0","summary":"BRIEF-4Dmedical Creates EU Platform Via Contextflow AcquisitionJune 1 (Reuters) - 4DMedical Ltd 4DX.AX:4DMEDICAL CREATES EU PLATFORM VIA CONTEXTFLOW ACQUISITIONESTABLISHES EUROPEAN COMMERCIAL AND CLIN","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nTUENYJK0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["4DX.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640811089","title":"BUZZ-Australia's 4DMedical rises on establishing European platform via acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2640811089","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640811089?lang=en_us&edition=fundamental","pubTime":"2026-06-01 08:43","pubTimestamp":1780274598,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's 4DMedical rises on establishing European platform via acquisition** Shares of 4DMedical 4DX.AX rise as much as 7.8% to A$4.28, their highest level since May 19** The medtech firm establishes an immediate European commercial and clinical platform, expanding operations to a third major region alongside North America and ANZ** Expansion accelerated via binding agreement to buy Austrian-based contextflow GmbH, a medical technology firm specialising in lung cancer screening, advanced AI-driven thoracic imaging, adds company** Acquisition agreed on heavily discounted terms including upfront payments of A$18.56 million  in cash, others** Stock up 6.4% this year, including the day's move  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nL4N429018:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","4DX.AU","AN3PL.AU","BK7094","ANZ.AU","BK7135"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":2,"totalSize":103,"code":"91000000","status":"200"}]}}